- Home
- EIC
as 12-20-2024 3:35pm EST
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 287.1M | IPO Year: | 2019 |
| Target Price: | N/A | AVG Volume (30 days): | 116.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 0.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.00 - $16.48 | Next Earning Date: | 11-14-2023 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Eagle Point Income Company Inc. News
EIC Breaking Stock News: Dive into EIC Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Eagle Point Income Company Inc. Announces Third Quarter 2024 Financial Results
Business Wire
a month ago
Eagle Point Income Company Inc. Announces First Quarter 2025 Common and Preferred Distributions
Business Wire
2 months ago
Eagle Point Income Company Inc. Schedules Release of Third Quarter 2024 Financial Results on Thursday, November 14, 2024
Thomson Reuters StreetEvents
4 months ago
Q2 2024 Eagle Point Income Company Inc Earnings Call
Business Wire
4 months ago
Eagle Point Income Company Inc. Announces Second Quarter 2024 Financial Results
Business Wire
5 months ago
Eagle Point Income Company Inc. Announces Fourth Quarter 2024 Common and Preferred Distributions
Business Wire
5 months ago
Eagle Point Income Company Inc. Schedules Release of Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
Yahoo Finance Video
6 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare EIC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EIC Eagle Point Income Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.